Profile data is unavailable for this security.
About the company
JD Health International Inc is a China-based investment holding company principally engaged in the Internet + Healthcare ecosystem business. The Company mainly providing pharmaceutical and healthcare products and Internet healthcare, health management, intelligent healthcare solutions to the customers, as well as a variety of marketing services to the business partners. The Company mainly conducts its businesses in domestic market.
- Revenue in HKD (TTM)58.83bn
- Net income in HKD2.81bn
- Incorporated2018
- Employees3.18k
- LocationJD Health International Inc8th Floor, Building C No. 18 Kechuang 11, Yizhuang Economic and TechnologicalDevelopment Zone, Daxing DistrictBEIJING 101111ChinaCHN
- Websitehttps://ir.jdhealth.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Welcia Holdings Co Ltd | 62.29bn | 1.10bn | 19.65bn | 15.29k | 17.54 | 1.56 | 8.48 | 0.3154 | 106.05 | 106.05 | 5,982.48 | 1,194.41 | 2.11 | 6.31 | 17.08 | 80,917,640.00 | 3.67 | 5.76 | 6.63 | 10.23 | 30.23 | 30.81 | 1.74 | 2.51 | 0.6511 | 38.94 | 0.2343 | 23.97 | 6.38 | 9.33 | -2.14 | 8.71 | 2.59 | 10.12 |
| Dashenlin Pharmaceutical Group Co Ltd | 28.54bn | 914.32m | 19.69bn | 45.47k | 21.60 | 2.67 | -- | 0.69 | 0.7445 | 0.7445 | 23.37 | 6.03 | 1.12 | 4.14 | 23.28 | 583,716.30 | 3.90 | 6.57 | 8.15 | 12.63 | 33.80 | 37.51 | 3.47 | 5.54 | 0.598 | 7.15 | 0.5981 | 45.67 | 15.45 | 22.59 | 12.63 | 17.02 | 26.51 | 6.85 |
| Yifeng Pharmacy Chain Co Ltd | 25.72bn | 1.64bn | 30.70bn | 39.65k | 18.71 | 2.78 | -- | 1.19 | 1.26 | 1.26 | 19.77 | 8.46 | 0.9734 | 4.00 | 14.51 | 603,225.00 | 6.72 | 6.93 | 12.76 | 12.47 | 38.47 | 38.73 | 6.90 | 6.71 | 0.8771 | 34.97 | 0.5237 | 26.56 | 13.59 | 26.72 | 11.57 | 27.66 | 25.93 | 33.54 |
| MatsukiyoCocokara & Co | 52.40bn | 2.59bn | 42.35bn | 13.37k | 16.33 | 1.63 | 11.22 | 0.8082 | 123.90 | 123.90 | 2,504.46 | 1,240.24 | 1.47 | 4.82 | 18.12 | 77,817,220.00 | 7.30 | 6.80 | 9.56 | 8.87 | 34.85 | 33.45 | 4.98 | 4.57 | 1.21 | -- | 0.0374 | 28.65 | 7.49 | 12.16 | 29.11 | 15.90 | 29.38 | 11.10 |
| Alibaba Hlth Infrmtn Tchnlgy Ltd | 30.45bn | 1.30bn | 60.51bn | 1.42k | 45.06 | 3.69 | 44.64 | 1.99 | 0.0834 | 0.0834 | 1.98 | 1.02 | 1.36 | 12.96 | 39.09 | 21,217,590.00 | 5.79 | 1.89 | 7.62 | 2.54 | 23.15 | 21.67 | 4.26 | 1.49 | 2.11 | -- | 0.0044 | 0.00 | 0.9847 | 39.61 | 64.93 | -- | 30.14 | -- |
| JD Health International Inc | 58.83bn | 2.81bn | 91.25bn | 3.18k | 32.12 | 1.63 | 29.93 | 1.55 | 0.8904 | 0.8904 | 18.61 | 17.56 | 0.8519 | 7.84 | 157.40 | 18,866,800.00 | 4.07 | -8.61 | 5.16 | -10.70 | 22.57 | 22.76 | 4.78 | -10.39 | 3.35 | -- | 0.0042 | -- | 14.54 | 45.64 | 463.49 | 58.38 | 95.69 | -- |
Data as of Nov 22 2024. Currency figures normalised to JD Health International Inc's reporting currency: Hong Kong Dollar HKD
7.25%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Krane Funds Advisors LLCas of 07 Nov 2024 | 55.36m | 1.74% |
| The Vanguard Group, Inc.as of 06 Nov 2024 | 37.79m | 1.19% |
| CSOP Asset Management Ltd.as of 07 Nov 2024 | 28.02m | 0.88% |
| Hang Seng Investment Management Ltd.as of 08 Nov 2024 | 19.90m | 0.62% |
| China Asset Management Co., Ltd.as of 30 Jun 2024 | 19.34m | 0.61% |
| BlackRock Fund Advisorsas of 07 Nov 2024 | 18.47m | 0.58% |
| JPMorgan Asset Management (Asia Pacific) Ltd.as of 30 Sep 2024 | 16.64m | 0.52% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2024 | 13.69m | 0.43% |
| Capital Research & Management Co. (World Investors)as of 07 Nov 2024 | 11.75m | 0.37% |
| Norges Bank Investment Managementas of 30 Jun 2024 | 10.22m | 0.32% |
More ▼
Data from 30 Jun 2024 - 08 Nov 2024Source: FactSet Research Systems Inc.
